These two new “weight loss” drugs have been getting a lot of attention: Semaglutide, a GLP1 (glucagon like peptide 1) receptor agonist, and Tirzepatide, a dual GLP1, and GIP...
Semaglutide vs Tirzepatide
read more
These two new “weight loss” drugs have been getting a lot of attention: Semaglutide, a GLP1 (glucagon like peptide 1) receptor agonist, and Tirzepatide, a dual GLP1, and GIP...
Strategies to tackle stubborn fat loss, how the immune system gets involved, and more! In this week’s episode, Dr Elizabeth Yurth is back on the Biohacking Superhuman...
We provide foundational health with a cellular lens for health-motivated individuals who seek to optimize their well-being.